Journal of Medicinal Chemistry · 2006 · 47 citations · 7 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular PharmacologyStructure-activity RelationshipsEnzyme InhibitionMicrotubule-associated ProteinsAntimitotic ChemotherapyAntiproliferative AgentsAntiproliferative Drug ActionMicrotubule Polymerization InhibitionTubulin Polymerization Inhibitors
A novel series of 2-amino and 2'-aminocombretastatin derivatives were synthesized and evaluated for antitumor activity. Several compounds had excellent antiproliferative activity as inhibitors of tubulin polymerization. Compounds 11, 20, and 21 with IC(50) values of 1.6, 1.7, and 1.8 microM, respectively, exhibited more potent inhibition of tubulin polymerization than colchicine and approximately as active as combretastatin A-4. They also displayed antiproliferative activity with an IC(50) values ranging from 11 to 44 nM in a variety of human cell lines from different organs. Structure activity relationship information suggests that the NH(2) substituent at the 2-position of either ring A or ring B in combretastatin molecular skeleton may play an important role in the bioactivity of this series of compounds.
7
Differentiation and Definition of Vascular-Targeted Therapies
Dietmar W. Siemann, Michael C. Bibby, G. Dark et al. · Clinical Cancer Research · 2005 · 269 citations · Full text
Medicine, Oncology, Pharmacology +16
Mark Cushman, Dhanapalan Nagarathnam, Dhanushya Gopal et al. · Journal of Medicinal Chemistry · 1992 · 234 citations